Global Peripheral Venous Thrombectomy Devices Market Size By Type (Stroke, Deep Vein Thrombosis (DVT)), By Application (Hospital, Medical Center), By Region, And Segment Forecasts, 2023 to 2032

The Global Peripheral Venous Thrombectomy Devices Market was valued at USD 1.1 billion in 2023 and is projected to surpass USD 2.0 billion by 2031, expanding at a CAGR of 7.8% during the forecast period from 2023 to 2031. The rising incidence of deep vein thrombosis (DVT), growing awareness regarding minimally invasive procedures, and technological advancements in thrombectomy devices are pivotal in accelerating market growth. Increasing healthcare expenditure and the global aging population further drive the adoption of peripheral venous thrombectomy devices across hospitals and specialty clinics.

Drivers

1. Rising Incidence of Venous Thromboembolism (VTE):

A growing number of patients affected by DVT and pulmonary embolism (PE) is increasing the demand for effective thrombectomy procedures. Sedentary lifestyles, obesity, and cancer-associated thrombosis are key contributors to this trend.

2. Increasing Preference for Minimally Invasive Treatments:

Minimally invasive thrombectomy devices offer quicker recovery, fewer complications, and shorter hospital stays compared to traditional surgical interventions, making them the preferred choice among patients and physicians.

3. Technological Advancements:

Innovations such as aspiration-based, mechanical, and hybrid thrombectomy systems enhance procedural efficacy and patient outcomes, driving adoption globally.

Restraints

1. High Cost of Devices and Procedures:

The high cost of advanced thrombectomy devices and associated procedural expenses can limit adoption in low- and middle-income countries.

2. Risk of Device-Related Complications:

Despite being minimally invasive, thrombectomy devices carry risks such as vessel wall injury, distal embolization, and incomplete thrombus removal, which may hinder widespread usage.

Opportunity

1. Expanding Geriatric Population:

The aging population is more susceptible to venous thrombosis, creating sustained demand for thrombectomy devices, particularly in regions like Europe, Japan, and North America.

2. Market Penetration in Emerging Economies:

Healthcare reforms, improving infrastructure, and growing awareness in Asia-Pacific and Latin America are paving the way for increased market penetration and business expansion.

Market by System Type Insights

Based on system type, the Mechanical Thrombectomy Devices segment held the largest market share in 2023. These devices are widely used due to their effectiveness in clot removal, speed of action, and versatility across varying thrombus compositions. The Aspiration Thrombectomy Devices segment is expected to witness the highest growth, driven by advancements in catheter designs and the growing preference for less traumatic options in clinical practice.

Market by End-use Insights

By end-use, the Hospitals segment dominated the market in 2023, accounting for more than 60% of global revenue. The segment benefits from the availability of skilled professionals, advanced imaging equipment, and high patient footfall. Meanwhile, Ambulatory Surgical Centers (ASCs) are expected to grow at a robust pace due to cost-effectiveness and increasing adoption of outpatient procedures.

Market by Regional Insights

North America led the global market in 2023, driven by high awareness, favorable reimbursement policies, and a strong presence of key players. However, Asia-Pacific is expected to register the fastest growth rate during the forecast period due to rapid healthcare infrastructure development, rising medical tourism, and growing demand for non-surgical interventions in countries like India, China, and South Korea.

Competitive Scenario

Prominent players in the Global Peripheral Venous Thrombectomy Devices Market include:

Boston Scientific Corporation

Penumbra, Inc.

AngioDynamics, Inc.

Medtronic plc

BD (Becton, Dickinson and Company)

Teleflex Incorporated

Argon Medical Devices, Inc.

Johnson & Johnson (via subsidiaries)

These companies focus on innovation, regulatory approvals, and strategic collaborations to enhance their market footprint. For instance:

In 2024, Penumbra Inc. launched a next-gen mechanical thrombectomy system tailored for deep vein interventions.

In 2023, AngioDynamics received expanded FDA clearance for its AlphaVac System, enabling broader application across venous thromboembolic conditions.

Scope of Work – Global Peripheral Venous Thrombectomy Devices Market

Report Metric Details

Market Size (2023) USD 1.1 billion

Projected Market Size (2031